Welcome Guest HomeContact UsFAQCreate AccountPassword Reminder

by Category

ASMPRESS Categories
    ASMONLINE Categories
    ASMMEETINGS Categories
    ASMMEMBERSHIP Categories
      JOURNALS Categories
                Join Email Alert Lists
        Click to receive product announcement emails
        T136 Registration Fee (non-member) $45.00
        T136 Registration Fee (member) $25.00
        T136 Use of Molecular Methods in Clinical Bacteriology

        Date: February 26, 2013; 2:00 p.m. (EST)
        Speaker: Melissa B. Miller, Ph.D.

        Description: The goal of this session is to review the current state-of-the-art in molecular bacteriology.  Currently available FDA-approved/clear assays will be briefly reviewed along with a discussion of the advantages and disadvantages of using molecular techniques for routine diagnosis of bacterial infection/colonization. The organisms discussed will include Chlamydia trachomatis, Neisseria gonorrhoeae, MRSA/MSSA, vancomycin-resistant Enterococcus, Group B Streptococcus, Clostridium difficile, Bordetella pertussis, Mycobacterium tuberculosis and organisms causing sepsis.

        Intended Audience: The course is open to anyone! However, since it is a practical course, laboratory personnel (e.g., medical technologists, supervisors, and directors) with a minimum of a bachelors-degree and familiarity with clinical microbiology would benefit the most. Limited to U.S. and Canadian residents.

        Objectives: Following this session, the participants should be able to:

        • Recognize the breadth of molecular testing available for bacteria.
        • Recall two advantages of detecting select bacterial pathogens solely by molecular testing.
        • Cite one disadvantage of using molecular testing to diagnosis infections due to bacteria.

        People who bought this item also bought: